GlaxoSmithKline’s $5.1 Billion Acquisition of Tesaro

Ambrogio Visconti
Tagged:

Shearman & Sterling advised GlaxoSmithKline on the deal GlaxoSmithKline plc (LSE/NYSE: GSK) and TESARO Inc (NASDAQ: TSRO) have entered into a definitive agreement pursuant to which…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here